Ignite Creation Date:
2025-12-24 @ 7:10 PM
Ignite Modification Date:
2026-02-24 @ 5:07 AM
Study NCT ID:
NCT00087503
Status:
COMPLETED
Last Update Posted:
2008-04-01
First Post:
2004-07-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-04
Start Date Type:
None
Primary Completion Date:
2005-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-06
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-09
First Submit QC Date:
None
Study First Post Date:
2004-07-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-03-27
Last Update Post Date:
2008-04-01
Last Update Post Date Type:
ESTIMATED